Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BREMELANOTIDE vs BREXPIPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BREMELANOTIDE vs BREXPIPRAZOLE: Safety Overview

Metric BREMELANOTIDE BREXPIPRAZOLE
Total FAERS Reports 718 13,270
Deaths Reported 1 673
Death Rate 0.1% 5.1%
Hospitalizations 6 1,269
Average Patient Age 48.2 yrs 50.5 yrs
% Female Patients 94.8% 69.0%
FDA Approval Date Jun 21, 2019 Aug 11, 2022
Manufacturer Palatin Technologies Otsuka America Pharmaceutical, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription